Rheumatoid Arthritis Treatment in Johor Bahru

Rheumatoid arthritis affects roughly **0.5% of the Malaysian population** — about one person in two hundred. That is common enough that most extended families have someone, and uncommon enough that it is rarely recognised early. Here is what should be on the front of this page rather than buried in it. Guidelines recommend that anyone with suspected rheumatoid arthritis is referred to a rheumatologist **within six weeks** of symptoms starting, and that disease-modifying treatment begins **within twelve weeks**. That is not a bureaucratic target. Evidence suggests the first twelve weeks of rheumatoid arthritis may be a biologically distinct phase — the **window of opportunity** — in which starting a disease-modifying drug does something qualitatively different from starting the same drug later. Treated inside the window, joint erosion can be prevented and in some patients the disease can effectively be switched off. Treated after it, the aim shifts to controlling damage that has already begun. Rheumatoid arthritis destroys joints permanently. Cartilage and bone lost to uncontrolled inflammation do not come back, and every month of untreated disease is a month of erosion. Almost everyone loses the window, and the reason is entirely understandable. Joint pain gets attributed to age, to work, to a mattress, to the air-conditioning, to "angin" or to a bad posture, and a few weeks turn into a few months before anyone thinks of a doctor. By the time a diagnosis is made, the twelve weeks are long gone. So the practical instruction, and the one worth acting on today: **if the small joints of your hands or feet have been swollen and stiff — both sides, for more than a few weeks, with stiffness that is worst in the morning — that clock is already running.** Do not wait to see if it settles.

The commonest confusion is with osteoarthritis, and the two behave differently in ways you can observe yourself. **Morning stiffness is the most useful single discriminator.** In rheumatoid arthritis, stiffness on waking lasts **more than an hour**, often several, and eases with movement through the day. In osteoarthritis, stiffness lasts perhaps fifteen or twenty minutes and returns after use. If you need an hour of moving about before your hands work properly, that is an inflammatory pattern. **Which joints, and which pattern.** Rheumatoid arthritis characteristically affects the **small joints of the hands and feet, symmetrically** — the knuckles and the middle finger joints on both hands, and the joints at the base of the toes. It classically spares the joint at the very end of the finger, which osteoarthritis commonly affects. Symmetry matters: one painful knee is unlikely to be rheumatoid; both wrists and several knuckles on both hands is a different proposition. **Swelling that is soft and warm**, rather than the bony knobbly enlargement of osteoarthritis. **Better with use, worse with rest** — the opposite of mechanical joint pain. **Systemic features**, because rheumatoid arthritis is a disease of the whole body rather than only the joints: fatigue that is disproportionate and often precedes the joint symptoms, low-grade fever, weight loss, and a general sense of being unwell. An early sign patients notice before anything else: difficulty with the small movements of a Malaysian morning — opening a jar, turning a tap, buttoning a shirt, or squeezing out a cloth. Loss of grip strength often arrives before visible swelling. The disease also has effects beyond joints that are worth knowing about, because they change how seriously it should be taken: it accelerates cardiovascular disease and raises heart attack and stroke risk independently of the usual factors; it can affect the lungs, eyes and blood vessels; and it raises osteoporosis risk both directly and through the steroids sometimes used to treat it.

Blood tests support the diagnosis; they do not make it alone, and misunderstanding that causes both false reassurance and unnecessary alarm. **Rheumatoid factor (RF)** is positive in most people with rheumatoid arthritis — but also in a proportion of healthy people, in other autoimmune conditions, and in chronic infections. A positive RF in someone with no joint symptoms usually means nothing. **Anti-CCP antibodies** are more specific for rheumatoid arthritis and are the more useful test. A positive anti-CCP in someone with early joint symptoms is significant and predicts more aggressive disease. **Inflammatory markers — ESR and CRP** — measure inflammation and are used both for diagnosis and for tracking response to treatment. **A full blood count** frequently shows the anaemia of chronic disease. The crucial caveat: **around a fifth to a third of people with rheumatoid arthritis are "seronegative"** — both RF and anti-CCP negative. They have the same disease, with the same capacity to destroy joints, and they need the same urgent treatment. A negative blood test in someone with symmetrical small-joint swelling and prolonged morning stiffness does **not** exclude rheumatoid arthritis, and should not be used to close the case. X-rays in early disease are often normal, because erosions take time to appear. Ultrasound is more sensitive to early inflammation. What matters most is the clinical picture assessed promptly. If the pattern fits, referral should not wait for a test result to confirm it — that is precisely how the twelve-week window gets lost. At the clinic we take the history and examine the joints properly, run RF, anti-CCP, ESR, CRP and a full blood count on site, exclude the conditions that mimic it — gout, psoriatic arthritis, lupus, viral arthritis including chikungunya and dengue-associated joint pain, which are locally relevant — and refer urgently to rheumatology where the picture fits, rather than waiting.

Treatment is built on **disease-modifying antirheumatic drugs (DMARDs)**, which suppress the underlying immune process rather than only relieving pain. In Malaysia the most prescribed are **methotrexate and sulphasalazine**, with methotrexate use having risen roughly sixfold between 1997 and 2007 as the case for early aggressive treatment became clear. Hydroxychloroquine and leflunomide are also used, often in combination, and biologic agents are available for disease that does not respond. The modern approach is **treat-to-target**: set a goal of remission or low disease activity, review regularly, and escalate treatment until the target is reached rather than accepting partial control. Patients who stay on treatment consistently do substantially better than those who start and stop. **The single most important safety point on this page: methotrexate for rheumatoid arthritis is taken ONCE A WEEK, not daily.** Daily dosing errors cause severe bone marrow suppression and have killed people. Choose a fixed day, write it down, tell your family which day it is, and check the label every time. If you are ever unsure whether you have taken it, ask before taking another dose. Folic acid is prescribed alongside it, on different days, to reduce side effects. While on DMARDs you need **regular blood monitoring** — full blood count, liver and kidney function — on a schedule. Missing monitoring is not a minor omission; it is how a treatable problem becomes a serious one. Report promptly: a sore throat, fever, or mouth ulcers, which can signal low white cells; unusual bruising or bleeding; breathlessness or a new persistent cough; yellowing of the eyes. Methotrexate is **not safe in pregnancy** and must be stopped well before conception, by both women and men. If you are of childbearing age, this needs planning rather than discovering. Because DMARDs suppress the immune system, vaccination matters more, not less. **Live vaccines are generally avoided; influenza and pneumococcal vaccination are recommended** — see our influenza page. Screening for hepatitis B and tuberculosis is standard before starting biologic treatment, which is relevant in this region. Steroids are useful for rapid control while DMARDs take effect, and are not a long-term solution — prolonged use brings diabetes, osteoporosis, hypertension and infection risk. Alongside the drugs: keep moving, because rested joints stiffen; physiotherapy and occupational therapy genuinely help; stop smoking, which both raises the risk of developing rheumatoid arthritis and makes treatment work less well; and manage cardiovascular risk actively, because that is what most often shortens life in this condition. We are at No. 62, Jalan Kiambang, Taman Bunga Raya, 81700 Masai, Johor, open Monday to Thursday and Saturday 9AM to 9PM, Friday and Sunday 9AM to 3PM. Walk in, or call +60 7-251 1162. We do the initial assessment, the bloods, the ongoing DMARD monitoring between specialist appointments, and the vaccinations and cardiovascular risk management that go with it.